Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2004 of 6351
-
New grass allergy shot shows promise in reducing hay fever misery
Symptom relief CompletedPQGrass309 is aimed at exploring the expected average treatment effect of PQ Grass 27600 SU cumulative dose on symptom and medication score in a field setting. The study will enrol adult subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis (SAR) induced by grass po…
Phase 2/3 • Sponsor: Allergy Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Promising pancreatic cancer combo trial halted early
Disease control Stopped earlyThe purpose of this Phase II study is to assess the efficacy and safety of NIS793 with and without spartalizumab in combination with gemcitabine/nab-paclitaxel versus gemcitabine/nab-paclitaxel in previously untreated mPDAC.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Triple threat: new drug cocktail targets BRCA breast cancer
Disease control CompletedThe main purpose of this research study is to learn whether the investigational combination of olaparib, palbociclib, and fulvestrant is safe in patients with estrogen receptor-positive breast cancer and BRCA1 or BRCA2 mutations.
Phase 1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Blood test aims to catch hidden head and neck cancer early
Knowledge-focused OngoingThis research study will include patients with high risk locally advanced head and neck squamous cell carcinoma (LA-HNSCC) of the oral cavity, oropharynx, hypopharynx or larynx and patients that are starting on standard definitive treatment. Patients with both stage III HPV posit…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Promising drug may shrink brain tumors in relapsed lymphoma
Disease control OngoingThe purpose of this study is to test whether giving acalabrutinib is safe and effective in controlling relapsed central nervous system (CNS) lymphoma. Currently, there are no FDA-approved treatments for relapsed CNS lymphoma. Although acalabrutinib has not been approved for the t…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Blood pressure drug may shield young cancer patients from crippling bone disease
Prevention CompletedThis is a randomized unblinded Phase II clinical trial evaluating the impact of intensive antihypertensive control (targeted to the 50-75th percentile for age, sex, and height) compared to conventional antihypertensive control (targeted to the 90-95th percentile for age, sex, and…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Could a personalized probiotic ease autism symptoms?
Symptom relief CompletedThis is a study of the effect of a customized probiotic on children and adults with autism, including effects on autism symptoms and gastrointestinal symptoms.
Sponsor: Arizona State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Acupuncture with a jolt: new hope for shingles nerve pain?
Symptom relief CompletedThe investigators designed the multicenter randomized parallel controlled clinical trial of electroacupuncture on PHN which is rigorously designed and have an appropriate sample size, aiming to evaluate the efficacy and safety of electroacupuncture in pain relieving and pain remo…
Sponsor: Nanjing University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Could MRI replace CT for sharper cancer radiation planning?
Disease control Recruiting nowThis is a master protocol for a prospective Phase I-II study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatments.
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New cocktail of drugs aimed at halting bone metastases in prostate cancer
Disease control PausedThis phase I/II trial studies the best dose of M3814 when given together with radium-223 dichloride or with radium-223 dichloride and avelumab and to see how well they work in treating patients with castrate-resistant prostate cancer that had spread to other places in the body (m…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Heart stent study: can ultrasound cut repeat procedures?
Disease control OngoingIntravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) has been shown in clinical trials, registries, and meta-analyses to reduce recurrent events after PCI. This is accomplished by improving the angiographic result with lesion and vessel assessment to gu…
Sponsor: Medstar Health Research Institute • Aim: Disease control
Last updated Jun 26, 2026 15:58 UTC
-
App-Based lifestyle coaching aims to cut dementia risk in older adults
Prevention CompletedThe overarching aim is to develop and deploy a multidomain intervention delivered on a mobile application to help older adults reduce their risk for dementia by improving a set of modifiable lifestyle risk factors associated with cognitive decline/dementia. The targeted domains a…
Sponsor: LuciLab • Aim: Prevention
Last updated Aug 26, 2026 00:00 UTC
-
Precision drug tipifarnib targets rare HRAS cancers in kids
Disease control OngoingThis phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have recurred or spread to other places in the body (advanced), lymphoma, or histiocytic disorders, that have a genetic alteration in the gene HRAS. Tipifarnib may bl…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Brain zaps may boost memory in those at risk for Alzheimer's
Symptom relief OngoingMore than 5 million people live with Alzheimer's dementia (AD) in North America. No effective treatment exists yet probably because by the time AD has developed it is too late to intervene. Mild Cognitive Impairment (MCI) is a clinical state that typically precedes AD. In MCI, th…
Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New hope for japanese patients with rare bone marrow cancer
Disease control OngoingThe study will be conducted in compliance with the International Council for Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice (GCP) and applicable regulatory requirements. This is a Phase 1/2 multicenter, sing…
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Burn surgery infection risk: do antibiotics help or hurt?
Disease control Recruiting nowThe indication of antibiotic prophylaxis in burn patients remains highly controversial and hasn't reached a consensus. The objective of antibiotic prophylaxis would be to reduce the risk of post-operative local and systemic infections. Burn surgery is associated with a high risk …
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug duo aims to halt endometrial cancer growth
Disease control OngoingThis is a phase II single arm trial to determine the percentage of patients without evidence of disease progression on abemaciclib and letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until either unacceptab…
Phase 2 • Sponsor: Gynecologic Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for myeloma patients with kidney failure: targeted drug tested in dialysis patients
Disease control OngoingBelantamab mafodotin is an antibody-drug conjugate (ADC) containing humanized anti- B-cell maturation antigen (BCMA) monoclonal antibody (mAb). Renal impairment is a major complication of multiple myeloma (MM) and the majority of MM participants is either at risk or already has r…
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a Nurse's touch boost vein treatment outcomes?
Symptom relief CompletedChronic venous disease can cause pain, swelling, functional limitations, and reduced health-related quality of life. Ultrasound-guided foam sclerotherapy is commonly used to treat venous insufficiency. This randomized controlled trial evaluated whether a structured nursing interv…
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
New trial could change how doctors help CDH babies at birth
Disease control Recruiting nowIsolated CDH is a rare disease (1/3500) and displays a wide range of severity and outcome. Despite attempts to standardize the management of this disease at birth and during the first months of life, the mortality varies from 20 to 50% according to different hospitals in France a…
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC